IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: contrarian who wrote (1301)	10/7/1997 10:53:00 PM
From: Roger Cranwill	of 1762

Contrarian- Production was discussed at the annual meeting in May. IDEC has been making C2B8 24 hours a day for about the past year. With their proprietary expression techniques, the amount they've produced must be "boo coo". As a pharmacist, my concern was stability-if the FDA suddenly says they want more paperwork, or decide they want the production line changed, will the stuff already made be going bad before full FDA approval-not to worry, according to Dr. Rastetter-they freeze the stuff, and it keeps indefinitely (I know they have to put a specific date on each lot, but I imagine there's no concern). Anyway, they're at full production (for now, till they decide to build the $100 million dollar facility in either San Diego or San Antonio), with an extensive inventory of very stable antibody-what more can we ask? The only variable I can see is the demand-Roger

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next